Sumitomo Dainippon Pharma Co., Ltd.
Overview
Sumitomo Dainippon Pharma Co., Ltd. is a leading pharmaceutical company based in Japan, specializing in innovative research and development of treatments across various therapeutic areas. It operates as a public company with a global footprint, providing solutions to enhance human health and well-being.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Sumitomo Dainippon Pharma Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Sumitomo Dainippon Pharma Co., Ltd. holds 0 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- RANIRESTAT (AS-3201)Inactive2008-03-19
- DROXIDOPAInactive2007-05-23
- SM-5887 (AMRUBICIN HYDROCHLORIDE)Inactive2005-11-30
- SMP-986Inactive2005-04-13
- MEROPENEM BULK BLENDInactive2005-02-16
- MEROPENEMInactive1993-06-25
FDA compliance signals
4 FDA enforcement records linked to this company.
- 4832025-07-11
Validation lacking for sterile drug products
- 4832025-07-11
Computer control of master formula records
- 4832025-07-11
Cleaning System
- 4832025-07-11
Procedures for sterile drug products
Is this Sumitomo Dainippon Pharma Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.